About Neurotrack

Neurotrack is building the cognitive health platform of the future, giving people direct access to tools and technology to assess, strengthen, and monitor their cognitive health. The company, based in Silicon Valley, California was co-founded in 2012 by Elli Kaplan, and leading neuroscientists and researchers Stuart Zola, Ph.D., Elizabeth Buffalo, Ph.D., and Cecelia Manzanares. Neurotrack has additional offices in Tokyo and Vancouver.

Timeline of Events

JAN 2020

Sompo Partnership

Neurotrack partners with Sompo Holdings to launch the Neurotrack Cognitive Health Program to policyholders in Japan.

JUN 2019

Series C Funding

Neurotrack raises $21M in Series C funding round.

APR 2019

Research Grant Awarded

The National Institute of Aging, a division of the U.S. National Institutes of Health, awards Neurotrack with a $3.3M research grant.

NOV 2018

Dai-ichi Life Partnership

Neurotrack partners with Dai-ichi Life to launch its new dementia insurance product.

MAR 2018

Series B Funding

Neurotrack raises $13.7M in Series B funding round.

JAN 2016

Series A Funding

Neurotrack raises $7.5M in Series A funding round.


Neurotrack is Founded

Elli Kaplan co-founds Neurotrack with a mission to give people everywhere the tools to assess their risk for cognitive decline.

Meet Our Team

Executive Team

Elli Kaplan

Co-Founder and CEO

“What we’re building at Neurotrack matters - to families here and around the world, including mine.”

Sidney Chang

Chief Business Officer

“The financial implications of Alzheimer's are tremendous and daunting. I believe we have the ability to change lives while also making a positive economic impact on our healthcare systems.”

Mitch Underseth

Chief Financial Officer

“We have employees and investors committed to addressing a problem that affects nearly everyone around us.”

Jordan Glenn, Ph.D.

Senior Vice President, Clinical Development

“Alzheimer's isn't about just treatment, but prevention. Neurotrack is working to help stop Alzheimer's Disease before it even begins.”

Jeff Magnusson

Vice President, Engineering

“I have seen Alzheimers and dementia in my own family, and I'm at Neurotrack to leverage technology and find improvements for the millions of people who struggle with it today.”

Daisuke Iwase

Chairman, Asia Pacific

“Our footprint in Japan, the world's fastest aging society, will continue to provide us with invaluable insights to tackle Alzheimer's disease.”

Scientific Advisory Board

John Harrison, Ph.D.

Principal Consultant

Metis Cognition Ltd.

Michael Ropacki

Vice President of Clinical Development and US Site Head

Oryzon Genomics

Mike Poole, M.D.

Venture Partner

Biomatics Capital

Dorene Rentz, Psy.D.


Center for Alzheimer Research and Treatment, Brigham and Women's Hospital

Scientific Co-Founders

Stuart Zola Ph.D.

Interim Provost Executive Vice President Academic Affairs

Professor, Psychiatry & Behavioral Sciences

Emory University School of Medicine

Elizabeth Buffalo Ph.D.

Professor, Department of Physiology & Biophysics

University of Washington School of Medicine

Chief, Neuroscience Division

Washington National Primate Research Center

Cecelia Manzanares

Program Manager

Yerkes National Primate Research Center Emory University

Our Partners